welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Upcoming events – pivotal data loom for Novavax and Mallinckrodt
Welcome to your weekly digest of approaching regulatory and clinical readouts. Novavax is up 4% today thanks to topline results from a phase II trial showing that its Nanoflu influenza vaccine caused “vigorous immune responses” to four strains of flu, and that these responses were enhanced when the group’s Matrix-M adjuvant was added to the vaccine.
But an even more meaningful event is approaching. Novavax’s lead asset, a vaccine against respiratory syncytial virus, is in phase III, and after its disastrous failure two years ago in a study that was intended to be pivotal this is its last chance.
Resvax, also known as RSV F Vaccine since it targets the fusion protein of the virus, crashed out of the Resolve trial, testing it in prevention of moderate to severe RSV-associated lower respiratory tract disease, in mid-2016.
expertly curated content related to this topic
-
Attenuated Familial Adenomatous Polyposis: Disease Basics from Cancer.NetAttenuated Familial Adenomatous Polyposi...
-
Two Cases of Multiple Adenomas in the Ileal Pouch After Total Proctocolectomy in Patients with Familial Adenomatous ...Familial adenomatous polyposis (FAP) is ...
-
Gross Appearance of a Villous Adenomahttp://library.med.utah.edu/WebPath/jpeg...
-
Familial Adenomatous Polyposis (FAP)http://canprevent.com/wp-content/uploads...
-
Wireless Capsule Endoscopy in Detecting Small-Intestinal Polyps in Familial Adenomatous PolyposisAIM : To detect the prevalence of small ...
-
Evaluation of Management of Desmoid Tumours Associated with Familial Adenomatous Polyposis in Dutch PatientsBACKGROUND : The optimal treatment of de...
-
French Digestive Polyposis CohorteFrench cohorte about polyposis digestive...